The Top-Rated Suppliers of Lu-177 for Cancer Research
With carrier-added and noncarrier-added versions available, the right supplier can make the difference between a program that stalls and one that successfully reaches patients.
presented by
How the American Cancer Society Is Using LLMs to Accelerate Research
The American Cancer Society struck a multi-year collaboration with Layer Health, a healthcare AI company that uses LLMs to improve data abstraction and generate insights. The partners will abstract data from thousands of medical charts of patients enrolled in the American Cancer Society’s research studies, with the ultimate goal of shortening research timelines.
presented by
Redefining Payer Operations: Data-Driven Strategies for the Future of Healthcare
This eBook provides actionable strategies, real-world best practices to help payers stay ahead in a value-based care environment.
Bridging the Impact Gap in Cancer R&D
It is critical that we rightsize and redistribute available funds based on our knowledge of persistent cancer disparities to help more patients benefit from potentially lifesaving innovations and ensure no one is left behind.
Real-word health data firm launches with backing from WashU Medicine, BJC HealthCare
Health data company CuriMeta launched on Tuesday and announced the close of a $6 million seed funding round led by its two institutional partners, BJC HealthCare and the Washington University School of Medicine. The company's mission is to leverage its two institutional partners’ deep data resources to create more useful data that enables quicker discoveries of new diagnostics and medical interventions.
Leveraging aggregated data from patient communities to improve cancer care
For data to be truly valuable, it must take into consideration all the facets of the patient’s life. That will allow researchers to uncover new patterns in cancer prognosis, diagnosis and treatment.
The Cancer Moonshot and beyond: What we need to succeed
U.S. government support can advance health breakthroughs and make a significant difference. I encourage you to support the creation of ARPA-H and to take specific actions to let your legislator know its importance.
presented by
Immune Support on Demand: Ranking the Top Mobile IV Therapy Companies
Explore the top mobile IV therapy companies boosting immune health on demand, with standout services, expert care and innovative delivery across the U.S.
What if we captured the spirit and urgency of Covid-19 research to cure cancer?
Covid-19 stands as a litmus test for pushing the boundaries of standardized research processes. Let’s use this shared focus, urgency, and the new partnerships being forged, to invigorate and accelerate cancer research.
Kaite Couric uses her celebrity to boost cancer research and public awareness
Couric, who lost her husband at 41 to colorectal cancer two decades ago and a sister to pancreatic cancer, leverages her nonprofit Stand Up to Cancer to boost research while using her media platform to educate the public.
Big data and big pharma giants join forces on cancer research effort
Merck and Palantir Technologies are forming a joint research venture called Syntropy as a way to offer data analytics tools to healthcare organizations.
Fitbit, Dana-Farber to study whether weight loss prevents breast cancer recurrence
The goal is to see if the extra motivation from fitness trackers, Wi-Fi scales and health coaches can help the patients lose weight and, ultimately, prevent a return of the disease.
presented by
These Are the Top-Rated Autism Therapy Centers in Texas
There are a number of criteria for selecting the best autism therapy centers. Parents choosing a facility or professionals seeking to improve their offerings should consider certain standards to ensure the right fit.
Our risk of getting cancer has more to do with luck than our lifestyle
We all know that certain behaviors like smoking, spending too much time in the sun, drinking excessively or an unhealthy diet can put us at risk for developing cancer. But according to some new research published in Science, unlucky, random cell mutation is the reason behind two thirds of cancer cases. Cristian Tomasetti and Bert […]